471 related articles for article (PubMed ID: 29622080)
1. Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer.
Shroff GS; de Groot PM; Papadimitrakopoulou VA; Truong MT; Carter BW
Radiol Clin North Am; 2018 May; 56(3):485-495. PubMed ID: 29622080
[TBL] [Abstract][Full Text] [Related]
2. Post-chemotherapy and targeted therapy imaging of the chest in lung cancer.
Carter BW; Altan M; Shroff GS; Truong MT; Vlahos I
Clin Radiol; 2022 Jan; 77(1):e1-e10. PubMed ID: 34538577
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Non-Small Cell Lung Cancer Treatment: Current Status and the Role of Imaging.
Carter BW; Halpenny DF; Ginsberg MS; Papadimitrakopoulou VA; de Groot PM
J Thorac Imaging; 2017 Sep; 32(5):300-312. PubMed ID: 28786858
[TBL] [Abstract][Full Text] [Related]
4. Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.
Dimou A; Sherman C; Wrangle J
J Thorac Imaging; 2016 Jul; 31(4):238-42. PubMed ID: 27306389
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy and Immunotherapy for Lung Cancer.
Naylor EC; Desani JK; Chung PK
Surg Oncol Clin N Am; 2016 Jul; 25(3):601-9. PubMed ID: 27261918
[TBL] [Abstract][Full Text] [Related]
6. Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment.
Tan L; Solomon B
PET Clin; 2018 Jan; 13(1):33-42. PubMed ID: 29157384
[TBL] [Abstract][Full Text] [Related]
7. [Lung cancer therapy in transition: targeted therapies are coming].
Grohé C
Dtsch Med Wochenschr; 2015 Mar; 140(5):316. PubMed ID: 25734671
[No Abstract] [Full Text] [Related]
8. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
Osmani L; Askin F; Gabrielson E; Li QK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
[TBL] [Abstract][Full Text] [Related]
9. Imaging on Lung Cancer and Treatment with Targeted Therapy.
Shroff GS; Benveniste MF; de Groot PM; Carter BW; Wu CC; Viswanathan C; Truong MT
Semin Ultrasound CT MR; 2018 Jun; 39(3):308-313. PubMed ID: 29807641
[TBL] [Abstract][Full Text] [Related]
10. Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Rijavec E; Genova C; Alama A; Barletta G; Sini C; Pronzato P; Coco S; Dal Bello MG; Savarino G; Truini A; Boccardo F; Grossi F
Future Oncol; 2014 Jan; 10(1):79-90. PubMed ID: 24328411
[TBL] [Abstract][Full Text] [Related]
11. Biological therapies in nonsmall cell lung cancer.
Zugazagoitia J; Molina-Pinelo S; Lopez-Rios F; Paz-Ares L
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28254765
[TBL] [Abstract][Full Text] [Related]
12. Combining Immunotherapy with Radiation Therapy in Non-Small Cell Lung Cancer.
Fitzgerald K; Simone CB
Thorac Surg Clin; 2020 May; 30(2):221-239. PubMed ID: 32327181
[TBL] [Abstract][Full Text] [Related]
13. Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer.
Sepesi B; Cascone T; Chun SG; Altan M; Le X
Surg Oncol Clin N Am; 2020 Oct; 29(4):555-569. PubMed ID: 32883458
[TBL] [Abstract][Full Text] [Related]
14. Management of stage III non-small cell lung cancer.
Tabchi S; Kassouf E; Rassy EE; Kourie HR; Martin J; Campeau MP; Tehfe M; Blais N
Semin Oncol; 2017 Jun; 44(3):163-177. PubMed ID: 29248128
[TBL] [Abstract][Full Text] [Related]
15. Multimodality Therapy for NSCLC.
Du L; Waqar SN; Morgensztern D
Cancer Treat Res; 2016; 170():151-63. PubMed ID: 27535393
[TBL] [Abstract][Full Text] [Related]
16. Pearls and Pitfalls in the Imaging of Targeted Therapy and Immunotherapy in Lung Cancer.
Ahuja J; Shroff GS; Strange CD; Vlahos I; Benveniste MFK; Truong MT
Semin Ultrasound CT MR; 2021 Dec; 42(6):552-562. PubMed ID: 34895611
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
18. Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report.
Tunali I; Gray JE; Qi J; Abdalah M; Jeong DK; Guvenis A; Gillies RJ; Schabath MB
Lung Cancer; 2019 Mar; 129():75-79. PubMed ID: 30797495
[TBL] [Abstract][Full Text] [Related]
19. Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer.
Ruiz-Cordero R; Devine WP
Surg Pathol Clin; 2020 Mar; 13(1):17-33. PubMed ID: 32005431
[TBL] [Abstract][Full Text] [Related]
20.
Ohri N; Bodner WR; Halmos B; Cheng H; Perez-Soler R; Keller SM; Kalnicki S; Garg M
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):372-380. PubMed ID: 28068244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
